Cerity Partners LLC Biotechnology

Cerity Partners LLC

$48.7 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ADGI Adagio Therapeutics, Inc.	$505M	$130,000 0.0% of portfolio	39,293	Q1 2025 New
ABCL Ab Cellera Biologics Inc.	$624M	$118,000 0.0% of portfolio	53,057	Q3 2024 Added 158.1%
DAWN Day One Biopharmaceuticals, Inc.	$549M	$118,000 0.0% of portfolio	14,999	Q1 2025 New
BCYC Bicycle Therapeutics PLC	$269M	$113,000 0.0% of portfolio	13,350	Q1 2025 New
VERV Verve Therapeutics, Inc.	$309M	$110,000 0.0% of portfolio	24,104	Q1 2025 New
PGEN Precigen, Inc.	$316M	$101,000 0.0% of portfolio	68,315	Q1 2025 Reduced 1.12%
VIR Vir Biotechnology, Inc.	$816M	$97,000 0.0% of portfolio	15,021	Q1 2025 New
AUPH Aurinia Pharmaceuticals Inc.	$1.17B	$96,000 0.0% of portfolio	11,981	Q1 2025 New
MRSN Mersana Therapeutics, Inc.	$35M	$83,000 0.0% of portfolio	244,235	Q1 2025 New
LXRX Lexicon Pharmaceuticals, Inc.	$136M	$78,000 0.0% of portfolio	170,387	Q1 2025 Added 76.54%
SANA Sana Biotechnology, Inc.	$356M	$77,000 0.0% of portfolio	46,181	Q1 2025 Added 200.27%
ATAI Atai Life Sciences N.V.	$244M	$63,000 0.0% of portfolio	46,483	Q1 2025 Reduced 3.45%
EDIT Editas Medicine, Inc.	$106M	$56,000 0.0% of portfolio	49,060	Q1 2025 New
VTYX Ventyx Biosciences, Inc.	$78M	$56,000 0.0% of portfolio	49,106	Q1 2025 New
NKTX Nkarta, Inc.	$96.3M	$54,000 0.0% of portfolio	29,770	Q1 2025 New
ALEC Alector, Inc.	$95.8M	$51,000 0.0% of portfolio	41,564	Q1 2025 New
NKTR Nektar Therapeutics	$129M	$51,000 0.0% of portfolio	75,920	Q1 2025 New
ERAS Erasca, Inc.	$177M	$48,000 0.0% of portfolio	35,504	Q1 2025 New
KOD Kodiak Sciences Inc.	$256M	$46,000 0.0% of portfolio	16,513	Q1 2025 Reduced 1.47%
CHRS Coherus Bio Sciences, Inc.	$79.3M	$44,000 0.0% of portfolio	54,676	Q1 2025 Added 83.95%
BMEA Biomea Fusion, Inc.	$58.6M	$37,000 0.0% of portfolio	17,500	Q1 2025 New
CRBU Caribou Biosciences, Inc.	$52.3M	$37,000 0.0% of portfolio	40,722	Q1 2025 Added 163.56%
SGMO Sangamo Therapeutics, Inc	$113M	$36,000 0.0% of portfolio	55,000	Q1 2025 Added 439.22%
ZNTL Zentalis Pharmaceuticals, Inc.	$77.5M	$32,000 0.0% of portfolio	20,501	Q1 2025 Added 58.65%
GERN Geron Corp	$537M	$27,000 0.0% of portfolio	17,176	Q1 2025 Reduced 20.5%
PRLD Prelude Therapeutics Inc	$29.5M	$26,000 0.0% of portfolio	34,565	Q1 2025 Added 5.13%
ADCT Adc Therapeutics Sa	$110M	$25,000 0.0% of portfolio	17,912	Q1 2025 New
STRO Sutro Biopharma, Inc.	$53.7M	$25,000 0.0% of portfolio	39,065	Q1 2025 New
FATE Fate Therapeutics Inc	$113M	$23,000 0.0% of portfolio	29,904	Q1 2025 Reduced 96.37%
APLT Applied Therapeutics Inc.	$19.2M	$16,000 0.0% of portfolio	34,337	Q1 2025 New
GOSS Gossamer Bio, Inc.	$117M	$15,000 0.0% of portfolio	13,761	Q1 2025 New
IGMS Igm Biosciences, Inc.	$37.4M	$15,000 0.0% of portfolio	13,106	Q1 2025 Added 24.82%
RANI Rani Therapeutics Holdings, Inc.	$25.7M	$12,000 0.0% of portfolio	10,000	Q3 2024 New
TNYA Tenaya Therapeutics, Inc.	$19.9M	$12,000 0.0% of portfolio	21,912	Q1 2025 New
IPSC Century Therapeutics, Inc.	$33M	$6,000 0.0% of portfolio	14,260	Q1 2025 New
CNTX Context Therapeutics Inc.	$13.9M	$6,000 0.0% of portfolio	10,000	Q3 2024 New
GBIO Generation Bio Co.	$24.2M	$6,000 0.0% of portfolio	16,852	Q1 2025 New
LYEL Lyell Immunopharma, Inc.	$107M	$6,000 0.0% of portfolio	12,706	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.